| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0069 | 0.9 |